Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.19 USD | -0.58% | -1.17% | +3.81% |
05-08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.81% | 7.13B | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating